Triggering ovulation with leuprolide acetate (LA) instead of human chorionic gonadotropin (hCG) after the use of ganirelix for in vitro fertilization-embryo transfer (IVF-ET) does not compromise cycle outcome and may prevent ovarian hyperstimulation syndrome.
2001 ◽
Vol 76
(3)
◽
pp. S93
◽
1993 ◽
Vol 10
(7)
◽
pp. 480-482
◽
2017 ◽
Vol 35
(2)
◽
pp. 297-307
2005 ◽
Vol 84
(1)
◽
pp. 93-98
◽
2017 ◽
Vol 35
(2)
◽
pp. 309-309
◽
1993 ◽
Vol 10
(2)
◽
pp. 126-129
◽
1988 ◽
Vol 5
(2)
◽
pp. 81-84
◽
1978 ◽
Vol 30
(1)
◽
pp. 27-35
◽